Lucid Diagnostics Inc. Costs and Expenses, Related Party
Lucid Diagnostics Inc. (LUCD) reported Costs and Expenses, Related Party of $442.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostsAndExpensesRelatedParty · last filed 2023-11-13
- Lucid Diagnostics Inc. costs and expenses, related party for the quarter ending 2023-09-30 was $442.00K, a 26.29% increase year-over-year.
- Lucid Diagnostics Inc. costs and expenses, related party for the quarter ending 2023-06-30 was $71.00K, a 86.92% decline year-over-year.
- Lucid Diagnostics Inc. costs and expenses, related party for the quarter ending 2023-03-31 was $646.00K, a 91.12% increase year-over-year.
- Lucid Diagnostics Inc. costs and expenses, related party for the quarter ending 2022-12-31 was $419.00K, a 19.71% increase year-over-year.
- Lucid Diagnostics Inc. costs and expenses, related party for fiscal 2022 was $1.65M, a 23.24% increase from fiscal 2021.
- Lucid Diagnostics Inc. costs and expenses, related party for fiscal 2021 was $1.34M, a 184.08% increase from fiscal 2020.
- Lucid Diagnostics Inc. costs and expenses, related party for fiscal 2020 was $471.00K.
| Period end | Costs and Expenses, Related Party 3 month | Costs and Expenses, Related Party 3 month as first filed | Costs and Expenses, Related Party 6 month | Costs and Expenses, Related Party 9 month | Costs and Expenses, Related Party 9 month as first filed | Costs and Expenses, Related Party 12 month |
|---|---|---|---|---|---|---|
| 2023-09-30 | $442.00K 10-Q · filed 2023-11-13 | $513.00K derived: sum of 2 quarters · filed 2023-11-13 | $1.16M 10-Q · filed 2023-11-13 | $1.58M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2023-06-30 | $71.00K 10-Q · filed 2023-08-14 | $718.00K 10-Q · filed 2023-08-14 | $1.14M derived: sum of 3 quarters · filed 2023-08-14 | $1.49M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2023-03-31 | $646.00K 10-Q · filed 2023-05-15 | $1.06M derived: sum of 2 quarters · filed 2023-05-15 | $1.42M derived: sum of 3 quarters · filed 2023-11-13 | $1.96M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-12-31 | $419.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $769.00K derived: sum of 2 quarters · filed 2023-11-13 | $1.31M derived: sum of 3 quarters · filed 2023-11-13 | $1.65M 10-K · filed 2023-03-14 | ||
| 2022-09-30 | $350.00K 10-Q · filed 2023-11-13 | $893.00K derived: sum of 2 quarters · filed 2023-11-13 | $1.23M 10-Q · filed 2023-11-13 | $1.58M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $543.00K 10-Q · filed 2023-08-14 | $882.00K 10-Q · filed 2023-08-14 | $1.23M derived: sum of 3 quarters · filed 2023-08-14 | $1.67M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $338.00K 10-Q · filed 2023-05-15 | $688.00K derived: sum of 2 quarters · filed 2023-05-15 | $1.13M derived: sum of 3 quarters · filed 2023-05-15 | $1.57M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $350.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $789.00K derived: sum of 2 quarters · filed 2023-03-14 | $1.23M derived: sum of 3 quarters · filed 2023-03-14 | $1.34M 10-K · filed 2023-03-14 | ||
| 2021-09-30 | $439.00K 10-Q · filed 2022-11-14 | $438.89K 10-Q · filed 2021-11-23 | $878.00K derived: sum of 2 quarters · filed 2022-11-14 | $988.00K 10-Q · filed 2022-11-14 | $987.90K 10-Q · filed 2021-11-23 | $1.21M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $439.00K 10-Q · filed 2022-08-15 | $549.00K 10-Q · filed 2022-08-15 | $775.55K derived: sum of 3 quarters · filed 2022-08-15 | $881.25K derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $110.00K 10-Q · filed 2022-05-16 | $336.55K derived: sum of 2 quarters · filed 2022-05-16 | $442.25K derived: sum of 3 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $226.55K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $332.25K derived: sum of 2 quarters · filed 2022-04-06 | $471.00K 10-K · filed 2022-04-06 | |||
| 2020-09-30 | $105.70K 10-Q · filed 2021-11-23 | $244.45K 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |